novel
coronaviru
isol
identifi
wuhan
china
februari
accord
world
health
organ
number
confirm
case
worldwid
among
new
case
record
last
hour
drug
vaccin
human
anim
coronaviru
inhibit
hydrolas
enzym
provid
promis
therapeut
principl
develop
treatment
mpro
known
involv
counteract
host
innat
immun
respons
work
present
inhibitori
effect
natur
compound
hydrolas
enzym
explain
main
interact
inhibitorenzym
complex
molecular
dock
studi
carri
use
autodock
vina
screen
sever
molecul
identifi
three
candid
agent
inhibit
main
proteas
coronaviru
hispidin
lepidin
e
folic
acid
bound
tightli
enzym
strong
hydrogen
bond
form
activ
site
residu
studi
provid
possibl
therapeut
strategi
coronavirus
includ
larg
divers
famili
envelop
positivestrand
rna
virus
latest
intern
committe
taxonomi
virus
ictv
classif
indic
thirtyeight
speci
coronavirus
belong
one
four
genera
princip
infect
mammal
seventeen
speci
among
host
bat
mersrcov
sarsrcov
princip
infect
bird
six
speci
cov
mersrcov
sarsrcov
infect
human
caus
diseas
sarscov
merscov
causal
agent
respiratori
diseas
outbreak
guangdong
provinc
china
middl
east
respect
novel
coronaviru
isol
identifi
wuhan
china
name
novel
coronaviru
address
correspond
author
depart
biolog
faculti
scienc
amar
telidji
univers
rout
de
bp
laghouat
email
tserseg
enslaghdz
kbenar
laghunivdz
gmailcom
februari
accord
world
health
organ
number
confirm
case
worldwid
among
new
case
record
last
hour
caus
death
china
death
outsid
coronaviru
hydrolas
mpro
enzym
also
known
main
proteas
exhibit
import
function
viral
lifecycl
inhibit
provid
promis
therapeut
principl
develop
treatment
prevent
spread
hydrolas
mpro
one
coronavirus
proteas
covmpro
becom
attract
target
anticov
drug
design
due
respons
matur
key
function
enzym
replicas
helicas
involv
counteract
host
innat
immun
respons
report
mpro
two
cov
infect
pig
antagon
host
immun
respons
cleav
porcin
nemo
ident
site
nemo
requir
activ
pathway
abrog
signal
inhibit
induct
mpro
pdcov
also
impair
jakstat
pathway
process
porcin
two
site
hispidin
polyphenol
import
medicin
metabolit
widespread
among
fungi
strophariacea
famili
genera
gymnopilu
pkarst
hypholoma
fr
pkumm
pholiota
fr
pkumm
hispidin
origin
isol
main
compound
inonotu
hipidu
bull
pkarst
pistacia
atlantica
tree
report
previou
studi
isol
method
hispidin
latter
antilipas
activ
found
medicin
mushroom
inonotu
phellinu
report
hispidin
exhibit
antivir
activ
seed
lepidium
sativum
rich
sourc
alkaloid
lepidin
b
e
major
compound
respect
previou
studi
prove
lepidin
b
e
antimicrobi
activ
curcumin
main
phytochem
curcuma
longa
l
rhizom
turmer
demonstr
curcumin
wide
rang
antivir
activ
differ
virus
includ
inhibitori
effect
proteas
studi
aim
identifi
potent
inhibitor
main
proteas
design
develop
drug
viral
infect
figur
role
main
proteas
pathogen
mechan
pdb
sequenc
file
genom
main
proteas
download
protein
data
bank
pdb
protein
sequenc
protein
sequenc
sarscov
conduct
brief
align
two
structur
mpro
use
similar
matrix
bioedit
softwar
inhibitori
effect
studi
compound
proteas
investig
blind
specif
dock
experi
molecul
obtain
pubchem
databas
structur
studi
molecul
repres
pdb
file
enzym
pdb
id
download
protein
data
bank
pdb
dock
protein
must
prepar
remov
water
molecul
heteroatom
ligand
cocrystal
solvent
polar
hydrogen
partial
charg
ad
structur
use
autodock
tool
adt
version
cocrystal
inhibitor
remov
molecular
dock
perform
autodock
vina
program
eight
cpu
station
softwar
use
rectangular
box
bind
site
center
box
set
display
use
adt
box
grid
blind
specif
dock
set
present
tabl
one
separ
grid
point
posit
middl
activ
site
default
set
use
except
number
output
conform
set
one
number
dock
run
set
run
number
solut
obtain
equal
conform
solut
well
handl
random
seed
random
prefer
conform
lower
bind
energi
within
activ
site
final
gener
dock
result
directli
load
discoveri
studio
visual
v
result
present
figur
main
proteas
sar
main
proteas
share
sequenc
ident
amino
acid
level
genom
nucleotid
ident
bat
human
sarscov
sequenc
align
main
proteas
sarscov
main
proteas
gener
bioedit
white
box
repres
differ
gray
box
repres
ident
two
amino
acid
sequenc
result
blind
specif
dock
studi
molecul
main
proteas
hydrolas
enzym
summar
tabl
respect
chymotrypsinlik
proteas
call
also
main
proteas
mpro
suggest
potenti
drug
target
combat
view
identifi
inhibitor
mpro
twentyon
drug
select
base
structur
conform
mpro
activ
site
present
tabl
result
show
three
molecul
hispidin
lepidin
e
folic
acid
could
bind
tightli
enzym
import
residu
substratebind
subsit
proteolyt
activ
involv
residu
form
hydrogen
bond
import
inhibitori
effect
mpro
molecular
dock
studi
demonstr
studi
molecul
bind
one
residu
best
molecul
hispidin
blind
dock
show
pose
activ
site
pose
share
posit
interact
proteas
residu
predic
bind
affin
proteas
kcalmol
hispidin
form
strong
hydrogen
bond
network
proteas
six
hydrogen
bond
observ
blind
specif
dock
strongest
hydrogen
bond
form
hydroxyl
group
benzen
ring
hispidin
co
hydroxyl
group
hispidin
residu
proteas
form
hydrogen
bond
hydrophob
interact
record
second
molecul
lepidin
e
pose
activ
site
ran
specif
dock
studi
bind
mode
lepidin
e
activ
site
b
lepidin
e
bind
tightli
proteas
residu
bind
affin
kcalmol
strong
short
hydrogen
bond
observ
hydroxyl
group
lepidin
e
length
blind
dock
specif
dock
respect
mean
form
coval
bond
may
lead
irrevers
inhibit
atom
lepidin
e
form
hydrogen
bond
proteas
residu
wherea
nh
imidazol
ring
bind
oxygen
atom
main
chain
interatom
distanc
id
oxygen
atom
hydroxyl
group
interact
nh
main
group
form
hydrogen
bond
length
respect
bind
support
hydrophob
interact
mean
respect
notic
lepidin
b
bind
proteas
differ
hydrogen
bond
length
respect
third
best
molecul
folic
acid
blind
dock
show
pose
activ
site
bind
affin
kcalmol
differ
posit
record
specif
dock
despit
observ
posit
contain
hydrogen
bond
hydrogen
bond
one
posit
frequent
pose
record
hydrogen
bond
c
strongest
hydrogen
bond
molecul
proteas
carboxyl
group
molecul
oxygen
atom
main
chain
carboxyl
group
molecul
also
form
hydrogen
bond
n
sidechain
residu
addit
hydrogen
bond
follow
molecul
co
nh
co
n
pteridin
ring
folic
acid
bind
nh
main
group
hydrogen
bond
lead
strong
bind
proteas
bind
site
pdb
file
crystal
structur
main
proteas
inhibitor
observ
inhibitor
bind
weaker
molecul
form
nine
hydrogen
bond
main
proteas
residu
hydrogen
bond
length
higher
shortest
hydrogen
bond
inhibitor
length
curcumin
show
also
strong
bind
affin
kcalmol
repeat
pose
four
hydrogen
bond
form
found
curcumin
inhibitori
effect
proteas
colchicin
febuxostat
aloxistatin
dhpehp
deriv
bind
strongli
bind
site
proteas
stabil
activ
site
mostli
hydrophob
interact
bind
affin
kcalmol
except
dhpehp
bind
affin
length
hydrogen
bond
alway
bigger
hydrogen
bond
form
colchicin
harmalin
harman
harmin
harmol
methoxi
norharman
sinc
publish
crystal
structur
main
proteas
mani
preprint
paper
perform
insilico
studi
identifi
inhibitor
number
drug
test
mpro
inhibitor
preprint
manuscript
among
nelfinavir
propos
potenti
inhibitor
anoth
studi
found
screen
clinic
drug
librari
small
molecular
drug
high
bind
capac
main
proteas
bind
manner
hydrogen
bond
format
activ
site
residu
discuss
studi
declar
commerci
medicin
may
form
hydrogen
bond
key
residu
main
proteas
accord
articl
publish
natur
commun
natur
review
drug
discoveri
sheahan
et
al
guangdi
et
al
current
four
drug
ritonavir
darunavir
cobicistat
consid
treatment
inhibitor
studi
recommend
enter
molecul
hispidin
lepidin
e
folic
acid
therapi
diseas
especi
studi
molecul
known
necessari
clinic
experi
alreadi
done
natur
compound
use
folk
medicin
treat
sever
diseas
found
hispidin
lepidin
e
folic
acid
display
strong
inhibitori
activ
enzym
prevent
spread
infect
stop
viru
cycl
life
base
studi
result
previou
studi
propos
therapeut
strategi
prevent
treat
viru
infect
potent
metabolit
hispidin
folic
acid
inhibit
main
proteas
might
effect
strategi
treat
novel
coronaviru
infect
individu
natur
molecul
also
might
becom
drug
candid
drug
